Search Results - "McLeod, Donald A"

Refine Results
  1. 1

    Controversies in primary treatment of low-risk papillary thyroid cancer by McLeod, Donald SA, FRACP, Sawka, Anna M, MD, Cooper, David S, Prof

    Published in The Lancet (British edition) (23-03-2013)
    “…Summary In many parts of the world, incidence of papillary thyroid cancer is increasing faster than any other malignancy. Most papillary thyroid cancers that…”
    Get full text
    Journal Article
  2. 2

    Thyrotropin and Thyroid Cancer Diagnosis: A Systematic Review and Dose-Response Meta-Analysis by McLeod, Donald S. A, Watters, Karen F, Carpenter, Anthony D, Ladenson, Paul W, Cooper, David S, Ding, Eric L

    “…Context: TSH is the major growth factor for thyrocytes and may have a causative role in thyroid cancer. Objective: The objective of the study was to…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Vitamin D and Sun Exposure: A Community Survey in Australia by Tran, Vu, Janda, Monika, Lucas, Robyn M, McLeod, Donald S A, Thompson, Bridie S, Waterhouse, Mary, Whiteman, David C, Neale, Rachel E

    Published in Current oncology (Toronto) (01-02-2023)
    “…Sun exposure carries both harms and benefits. Exposing the skin to the sun is the main modifiable cause of skin cancers, which exert a considerable health and…”
    Get full text
    Journal Article
  5. 5

    Calcitriol-Mediated Hypercalcemia: Causes and Course in 101 Patients by Donovan, Peter J, Sundac, Lana, Pretorius, Carel J, d'Emden, Michael C, McLeod, Donald S. A

    “…Context: Hypercalcemia mediated by 1,25-dihydroxy vitamin D (calcitriol) is uncommon, with evidence on etiology limited to small case series or case reports…”
    Get full text
    Journal Article
  6. 6

    Contemporary Debates in Adult Papillary Thyroid Cancer Management by McLeod, Donald S A, Zhang, Ling, Durante, Cosimo, Cooper, David S

    Published in Endocrine reviews (01-12-2019)
    “…Abstract An ever-increasing population of patients with papillary thyroid cancer is engaging with health care systems around the world. Numerous questions…”
    Get full text
    Journal Article
  7. 7

    Health-Related Quality of Life After Diagnosis and Treatment of Differentiated Thyroid Cancer and Association With Type of Surgical Treatment by Nickel, Brooke, Tan, Tessa, Cvejic, Erin, Baade, Peter, McLeod, Donald S A, Pandeya, Nirmala, Youl, Philippa, McCaffery, Kirsten, Jordan, Susan

    Published in JAMA otolaryngology-- head & neck surgery (01-03-2019)
    “…Concerns around possible overdiagnosis and overtreatment of differentiated thyroid cancer (DTC) have been raised. Issues concerning health-related quality of…”
    Get more information
    Journal Article
  8. 8

    Cost–utility analysis comparing radioactive iodine, anti-thyroid drugs and total thyroidectomy for primary treatment of Graves’ disease by Donovan, Peter J, McLeod, Donald S A, Little, Richard, Gordon, Louisa

    Published in European journal of endocrinology (01-12-2016)
    “…Objective Little data is in existence about the most cost-effective primary treatment for Graves’ disease. We performed a cost–utility analysis comparing…”
    Get full text
    Journal Article
  9. 9

    PTHrP-Mediated Hypercalcemia: Causes and Survival in 138 Patients by Donovan, Peter J, Achong, Naomi, Griffin, Katherine, Galligan, John, Pretorius, Carel J, McLeod, Donald S. A

    “…Context: Hypercalcemia is a common complication of cancer with PTHrP an important mediator. Literature on the underlying causes of PTHrP-mediated…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Clinical guidance for radioiodine refractory differentiated thyroid cancer by Gild, Matti L., Topliss, Duncan J., Learoyd, Diana, Parnis, Francis, Tie, Jeanne, Hughes, Brett, Walsh, John P., McLeod, Donald S.A., Clifton‐Bligh, Roderick J., Robinson, Bruce G.

    Published in Clinical endocrinology (Oxford) (01-04-2018)
    “…Summary Prognosis from differentiated thyroid cancer is worse when the disease becomes refractory to radioiodine. Until recently, treatment options have been…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Risk of thyroid cancer following hysterectomy by Rahman, Sabbir T., Pandeya, Nirmala, Neale, Rachel E., McLeod, Donald S.A., Baade, Peter D., Youl, Philippa H., Allison, Roger, Leonard, Susan, Jordan, Susan J.

    Published in Cancer epidemiology (01-06-2021)
    “…•Having undergone a hysterectomy was associated with increased thyroid cancer risk.•The association appeared stronger for those having hysterectomy to treat…”
    Get full text
    Journal Article
  15. 15

    Thyroid cancer by Chen, Debbie W, Lang, Brian H H, McLeod, Donald S A, Newbold, Kate, Haymart, Megan R

    Published in The Lancet (British edition) (06-05-2023)
    “…The past 5–10 years have brought in a new era in the care of patients with thyroid cancer, with the introduction of transformative diagnostic and management…”
    Get full text
    Journal Article
  16. 16

    The incidence and prevalence of thyroid autoimmunity by McLeod, Donald S. A., Cooper, David S.

    Published in Endocrine (01-10-2012)
    “…The thyroid gland is the most common organ affected by autoimmune disease. Other autoimmune diseases, most notably type 1 diabetes mellitus, are increasing in…”
    Get full text
    Journal Article
  17. 17

    Thyroid Dysfunction from Treatments for Solid Organ Cancers by Kotwal, Anupam, McLeod, Donald S.A.

    “…In recent years, cancer care has been transformed by immune-based and targeted treatments. Although these treatments are effective against various solid organ…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20